Tuberculosis, a re-emergent disease

European Journal of Radiology

Volumn 55, Issue 2, 2005, Pages 154-157

  Valadas, Emília ^a   Antunes, Francisco ^a  

^a UNIVERSITY OF LISBON   (Portugal)

Author keywords

DOTS; HIV; Multi drug resistance; Mycobacterium tuberculosis; Tuberculosis

Indexed keywords

DIAGNOSIS; DRUG DOSAGE; HEALTH CARE; PATIENT TREATMENT; RADIOLOGY; VIRUSES;

HIV INFECTION; MORBIDITY; MORTALITY; TUBERCULOSIS (TB);

PULMONARY DISEASES;

BCG VACCINE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BCG VACCINATION; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; HEALTH CARE; HEALTH CARE SYSTEM; HEALTH PROGRAM; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; MEDICAL RESEARCH; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH; REVIEW; SENSITIVITY ANALYSIS; SHORT COURSE THERAPY; TUBERCULOSIS; WESTERN EUROPE;

EID: 22144450297     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2005.04.013     Document Type: Article

References (47)

1. M.C. Raviglione, D.E. Snider, and A. Kochi Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic JAMA 273 1995 220 226
2. C. Dye, S. Scheele, P. Dolin, V. Pathania, and M.C. Raviglione Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project JAMA 282 7 1999 677 686
3. C.J.L. Murray, K. Styblo, and A. Rouillion DT. Jamison WH. Mosley Disease control priorities in developing countries 1992 Oxford University Press New York
4. Treatment of tuberculosis: guidelines for national programmes 2003 WHO (document WHO/CDS/TB/2003.313)
5. B.R. Bloom, and C.J. Murray Tuberculosis: commentary on a remergent killer Science 257 1992 1055 1064
6. Global tuberculosis control. WHO Report 2000. Geneva, WHO 2000 (document WHO/CDS/TB/2000.275).
7. WHO Memorandum from a WHO meeting. Plan of action for research in the immunology of tuberculosis Bull WHO 61 1983 779 785
8. M.C. Raviglione, P. Sudre, H.L. Rieder, S. Spinaci, and A. Kochi Secular trends of tuberculosis in Western Europe Bull WHO 71 1993 297 306
9. K. Brudney, and J. Dobkin Resurgent tuberculosis in New York city: human immunodeficiency virus, homeleness, and the decline of tuberculosis control programs Am Rev Respir Dis 144 1992 745 749
10. K.M. De Cock, B. Soro, I.M. Coulibaly, and S.B. Lucas Tuberculosis and HIV in sub-Saharan Africa JAMA 268 1992 1581 1587
11. A.M. Elliot, N. Luo, and G. Tembo Impact of HIV on tuberculosis in Zambia: a cross sectional study BMJ 301 1990 412 415
12. M.C. Raviglione, A.D. Harries, R. Msiska, D. Wilkinson, and P. Nunn Tuberculosis and HIV: current status in Africa AIDS 11 Suppl. B 1997 115 123
13. P.A. Selwyn, D. Hartel, and V.A. Lewis A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection N Engl J Med 320 9 1989 545 550
14. C.L. Daley, P.M. Small, G.F. Schecter, G.K. Schoolnik, R.A. McAdam, W.R. Jacobs Jr., and P.C. Hopewell An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms N Engl J Med 326 4 1992 231 235
15. G. Di Perri, M. Cruciani, and M.C. Danzi Nosocomial epidemic of active tuberculosis among HIV-infected patients Lancet 2 8678-8679 1989 1502 1504
16. E. Valadas, C. Constant, and P. Bravo Ferreira Multi-drug-resistant tuberculosis in a Department of Infectious Diseases Infect Genet Evol 85 2003 82
17. I. Portugal, M.J. Covas, and L. Brum Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis Int J Tuberc Lung Dis 3 3 1999 207 213
18. M.M. Hannan, H. Peres, and F. Maltez Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital J Hosp Infect 47 2 2001 91 97
19. C. Whalen, A. Okwera, and J. Johnson Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration Am J Resp Crit Care Med 153 1996 1977 1981
20. M.A. Espinal, A. Laszlo, and L. Simonsen Global trends in resistance to antituberculosis drugs. World Health Organization - International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance N Engl J Med 344 17 2001 1294 1303
21. P. Brown Drug resistant tuberculosis can be controlled, says WHO BMJ 320 7238 2000 821
22. M.A. Fischl, R.B. Uttamchandani, and G.L. Daikos An outbreak of tuberculosis caused by multiple drug-resistant bacilli among patients with HIV infection Ann Int Med 117 1992 177 183
23. M.L. Moro, I. Errante, and A. Infuso Effectiveness of infection control measures in controlling a nosocomial outbreak of multi-drug-resistant tuberculosis among HIV patients in Italy Int J Tuberc Lung Dis 4 2000 61 68
24. A.S. Breathnach, A. Ruiter, and G.M. Holdsworth An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital J Hosp Infect 92 1998 111 117
25. V.G. Coronado, C.M. Beck-Sague, and M.D. Hutton Transmission of multi-drug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis J Infect 1684 1993 1052 1055
26. Centers for Disease Control and Prevention Outbreak of multi-drug-resistant tuberculosis at a hospital - New York city, 1991 MMWR 4222 1993 427 433-4
27. A.E. Pitchenik, J. Burr, and M. Laufer Outbreaks of drug-resistant tuberculosis at AIDS center Lancet 336 1990 440 441
28. C. Conover, R. Ridzon, and S. Valway Outbreak of multi-drug-resistant tuberculosis at a methadone treatment program Int J Tuberc Lung Dis 1 2001 59 64
29. Centers for Disease Control and Prevention Transmission of multi-drug-resistant tuberculosis among immunocompromised persons in a correctional system - New York, 1991 MMWR 4128 1992 507 509
30. R.W. Shafer, P.M. Small, and C. Larkin Temporal trends and transmission patterns during the emergence of multi-drug-resistant tuberculosis in New York City: a molecular epidemiologic assessment J Infect Dis 171 1995 170 176
31. M.L. Moro, A. Gori, and I. Errante An outbreak of multi-drug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. Italian Multi-drug-Resistant Tuberculosis Outbreak Study Group AIDS 129 1998 1095 1102
32. G.A. Colditz, T.F. Brewer, and C.S. Berkey Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature JAMA 271 1994 698 702
33. J.W. Pape, S.S. Jean, J.L. Ho, A. Hafner, and WD. Johnson Jr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection Lancet 342 1993 268
34. C.C. Whalen, J.L. Johnson, and A. Okwera A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration N Engl J Med 337 1997 801
35. F.M. Gordin, R.E. Chaisson, and J.P. Matts Rifampin and pyrazinamide vs. isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. An international, randomized trial of rifampin and pyrazinamide versus isoniazid for prevention of tuberculosis in HIV infected persons JAMA 283 2000 1445
36. N.A. Halsey, J.S. Coberly, and J. Desormeaux Randomized trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection Lancet 352 1998 786 792
37. A.M. Mwinga, M. Hosp, and P. Godfrey-Faussett Twice weekly tuberculosis preventive therapy in HIV infection in Zambia AIDS 12 1998 2447
38. S.M. Arend, A.C. Engelhard, and G. Groot Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and non-specific antigens for detection of latent infection in persons with recent tuberculosis contact Clin Diagn Lab Immunol 8 6 2001 1089 1096
39. R.M. Nakamura, L. Einck, and M.A. Velmonte Detection of active tuberculosis by an MPB-64 transdermal patch: a field study Scand J Infect Dis 33 2001 405 407
40. P.G. Suarez, C.J. Watt, and E. Alarcon The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru J Infect Dis 184 4 2001 473 478
41. C. Dye, Z. Fengzeng, S. Scheele, and B. Williams Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China Int J Epidemiol 29 3 2000 558 564
42. T.R. Frieden, P.I. Fujiwara, R.M. Washko, and M.A. Hamburg Tuberculosis in New York city - turning the tide N Engl J Med 333 4 1995 229 233
43. Report of the Ad Hoc Committee on the Tuberculosis Epidemic, London, 17-19 March 1998. Geneva, WHO (document WHO/TB/98.245).
44. C. Dye, G.P. Garnett, K. Sleeman, and B.G. Williams Prospects for worldwide tuberculosis control under the WHO DOTS strategy Lancet 352 9144 1998 1886 1891
45. E. Valadas, T. Hänscheid, M.L. Fernandes, and F. Antunes Smear microscopy to diagnose tuberculosis early and prevent further transmission in a population with a high prevalence of HIV infection Clin Microbiol Infect 9 10 2003 1045 1047
46. J.P. Wisnivesky, J. Kaplan, C. Henschke, T.G. McGinn, and R.G. Crystal Evaluation of clinical parameters to predict Mycobacterium tuberculosis in inpatients Arch Intern Med 160 16 2000 2471 2476
47. J. Cobo, J. Oliva, and A. Asensio Predicting tuberculosis among HIV-infected patients admitted to hospital: Comparison of a model with clinical judgment of infectious disease specialists Eur J Clin Microbiol Infect Dis 20 11 2001 779 784